🇺🇸 FDA
Patent

US 8236987

Selective estrogen receptor modulator compositions and methods for treatment of disease

granted A61PA61P1/14A61P19/02

Quick answer

US patent 8236987 (Selective estrogen receptor modulator compositions and methods for treatment of disease) held by The Regents of the University of California expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61P, A61P1/14, A61P19/02, A61P19/08, A61P19/10